The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer

BACKGROUND: Prostate cancer (PC) is the most commonly diagnosed male malignancy and an important cause of mortality. Androgen deprivation therapy is the first line treatment but, unfortunately, a large part of patients evolves to a castration-resistant stage, for which no effective cure is currently...

Descripción completa

Detalles Bibliográficos
Autores principales: Chellini, Lidia, Pieraccioli, Marco, Sette, Claudio, Paronetto, Maria Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118622/
https://www.ncbi.nlm.nih.gov/pubmed/35590370
http://dx.doi.org/10.1186/s13046-022-02384-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118622/
https://www.ncbi.nlm.nih.gov/pubmed/35590370
http://dx.doi.org/10.1186/s13046-022-02384-4

Ejemplares similares